News

The 2007 approvable letter asked the company to conduct – An objective or subjective clinical trial in the elderly; a safety study assessing the rates of adverse events

The drug candidate, TMC435350, recently advanced into Phase II of the clinical trial program. The first Phase IIa study was initiated in Europe by Tibotec Pharmaceuticals at the

Under the terms of the collaboration between Exelixis and GlaxoSmithKline (GSK) initiated in October 2002 and amended in January 2005, GSK’s selection of XL880 entitles Exelixis to a

Efficacy endpoints in this post-operative abdominal surgery trial were the sum of the pain intensity differences (SPID), versus pre-treatment pain scores, over 0-48 hours and 0-24 hours. Patients

Aridol has already been approved in Europe by the mutual recognition procedure and is now awaiting confirmation of national approval in Portugal. Claimed to be a simple-to-use airways

Study 33CL231 will explore the analgesic efficacy of ADL5859 in treating pain associated with diabetic peripheral neuropathy. The study is a double-blind trial expected to enroll approximately 210

The study involves 210 patients with mild to moderate Alzheimer’s disease (AD). The trial is comparing the safety, tolerability and efficacy of either 200 or 400 micrograms of

Remedent has agreed to deliver the product in packed form and ready for sale, while the distributor will be responsible to promote and advertise the product to the

Results of the studies could provide the basis for developing a blood test that would enable early detection of breast cancer. According to A&G, the award was one